Maude, Shannon L <br/><br/>
Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response.  [electronic resource] 

 -  Cancer research  Feb 2005 
 - 780-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ataxia Telangiectasia Mutated Proteins<br/>CDC2 Protein Kinase--antagonists & inhibitors<br/>CDC2-CDC28 Kinases--antagonists & inhibitors<br/>Cell Cycle Proteins--metabolism<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>DNA Damage--physiology<br/>DNA-Binding Proteins--metabolism<br/>Down-Regulation<br/>Enzyme Inhibitors--pharmacology<br/>HeLa Cells<br/>Histones--metabolism<br/>Humans<br/>Kinetin<br/>Protein Kinases--biosynthesis<br/>Protein Serine-Threonine Kinases--metabolism<br/>Purines--pharmacology<br/>Roscovitine<br/>Tumor Suppressor Proteins--metabolism